Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $1.71 0.2800 +19.58%
ZIOP $3.24 0.4400 +15.71%
FATE $4.62 0.3900 +9.22%
TGTX $10.89 0.8400 +8.36%
ADXS $3.33 0.2500 +8.12%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

IMGN $8.75 -0.4700 -5.10%
AVEO $0.97 -0.0500 -4.90%
CVM $0.66 -0.0299 -4.33%
CERU $3.96 -0.1600 -3.88%
CYTR $2.80 -0.1100 -3.78%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Polaris Enrolls First Patient in Phase 2 Clinical Trial of ADI-PEG 20 for the Treatment of Malignant Mesothelioma

(Yahoo! Finance) Mar 18, 2011 - Polaris Group announced today the enrollment of the first patient in a Phase 2 clinical trial of ADI-PEG 20 (pegylated arginine deiminase), the company's novel enzyme-based treatment for malignant mesothelioma.
read article 

Stem Cells May Be Key to Understanding the Origins of Colon Cancer and Detecting Relapse

(IRB Barcelona) Mar 18, 2011 - Scientists at IRB Barcelona report new data in support of link between stem cells and cancer, opening door to new tools for diagnosis and treatment.
read press release 

First-in-man Study of E-3810 in Patients with Advanced Solid Tumors

(ESMO) Mar 16, 2011 - First report on a novel VEGFR and FGFR inhibitor.
read article 

NICE Gives Green Light to Romiplostim for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

(NICE) Mar 16, 2011 - The National Institute for Health and Clinical Excellence (NICE) has recommended romiplostim (Nplate, Amgen) for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) in some patients in draft guidance issued today (Thursday 17 March 2011). Final guidance is likely to be published in April 2011.
read press release 

Lilly Claim Over Hospira’s Gemzar Copy to Be Reviewed By ITC

(Bloomberg) Mar 17, 2011 - Eli Lilly & Co.’s patent-infringement claim over Hospira Inc.’s generic version of the cancer treatment Gemzar will be investigated by a U.S. trade agency with the power to block imports of the copycat drug.
read article 

European Regulators Give Thumbs Down to Amgen Drug

(Reuters) Mar 18, 2011 - Amgen Inc said on Friday that European regulators have declined to recommend approval of its drug Vectibix in combination with chemotherapy for patients with wild-type KRAS metastatic colorectal cancer.
read article 

FDA Panel Backs Experimental Brain-Cancer-Treatment Device

(Morningstar/Dow Jones Newswires) Mar 17, 2011 - A Food and Drug Administration panel backed a novel, noninvasive device that uses an electrical field designed to blast apart cancer cells as a potential treatment for brain cancer amid concerns about how well the device works.
read article 

Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer

(Taiho Pharmaceutical) Mar 14, 2011 - Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the European Commission (EC) has granted marketing authorization for Teysuno™ (S-1), a novel oral anti-cancer agent indicated for the treatment of adults with advanced gastric cancer when given in combination with cisplatin.
read press release 

Pack-a-day Smokers Declining

(CNNHealth) Mar 15, 2011 - The decline in heavy smoking appears to be linked to a subsequent decline in lung cancer.
read article 

Letters: There Is Medical Cost Shifting, but Not What You Think

(Wall Street Journal) Mar 17, 2011 - John F. Cogan, R. Glenn Hubbard and Daniel Kessler have it completely wrong on the "cost shifting" of health care from the uninsured to the insured ("ObamaCare and the Truth About 'Cost Shifting'," op-ed, March 11). It is not the insured who pay a price for the uninsured, it is the opposite.
read article (paid subscription required) 

Novartis to Cut 500 U.K. Jobs

(Wall Street Journal) Mar 16, 2011 - Novartis AG said Wednesday it plans to cut around 500 positions at its Horsham site in southern England as part of the Swiss drug giant's review of its global operations.
read article (paid subscription required) 

Study: Gene Therapy Improves Parkinson's Symptoms

(San Francisco Chronicle/AP) Mar 17, 2011 - An experimental treatment improved symptoms of Parkinson's disease in a mid-stage test, echoing results of an earlier pilot study.
read article 

UK's NICE Backs Merck's Rheumatoid Arthritis Drug

(Morningstar/Dow Jones Newswires) Mar 17, 2011 - The cost regulator for the U.K.'s publicly funded National Health Service Thursday recommended the use of Merck & Co. Inc.'s injectable anti-inflammatory drug Simponi, after the U.S.-based manufacturer provided more information about the product.
read article 

Medicare Proposes No Changes for Anemia Drugs

(Reuters) Mar 16, 2011 - Medicare officials do not plan at this time to change payment terms for anemia drugs used in kidney patients who are undergoing dialysis.
read article 

Drug Prices Rise Despite Calls for Cuts

(Wall Street Journal) Mar 17, 2011 - Even as government and private health plans push to restrain spending on medicines, the prices of brand name prescriptions are climbing rapidly, reaching the steepest rate of the decade last year.
read article (paid subscription required) 

Cancer Risks From Airport Screenings are Low, Expert Says

( Mar 16, 2011 - The risk to any one person of developing cancer from airport X-rays is extremely small, but given the large number of people that go through the machines each day, a small number of people, especially those who are particularly vulnerable or who fly often, could develop cancer, one scientist says.
read article 

Higher Cancer Risk Continues After Chernobyl

(NCI) Mar 17, 2011 - NIH study finds that thyroid cancer risk for those who were children and adolescents when exposed to fallout has not yet begun to decline.
read press release 

The American Cancer Society (ACS), "More Interested in Accumulating Wealth Than Saving Lives," According to a Report by Dr. Samuel Epstein, Chairman of the Cancer Prevention Coalition

(Yahoo! Finance) Mar 16, 2011 - A report on the American Cancer Society (ACS), "More Interested In Accumulating Wealth Than Saving Lives" was released today.
read article 

New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test

(StreetInsider) Mar 17, 2011 - Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state.
read article 

Sanofi-Aventis Taps Epistem to Inform Biomarker Strategy for Cancer Drug Development

(GEN News) Mar 17, 2011 - Sanofi-aventis will pay Epistem $4 million over three years in research support payments including reimbursement of certain costs to use its biomarker gene-expression profiling and immunohistochemistry technologies.
read article 

GenSpera Wins Patent on Prostate Cancer Drug

(San Antonio Business Journal) Mar 17, 2011 - The U.S. Patent and Trademark Office awarded GenSpera Inc. a patent on Ac-GKAFRR-L12ADT, the company’s drug that specifically targets prostate cancer.
read article 

New Technologies Open the Door for Low Dose Breast-Specific Gamma Imaging (BSGI) / Molecular Breast Imaging (MBI)

(Yahoo! Finance) Mar 17, 2011 - A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P. and North Cypress Medical Center in Houston, presented this week at the National Consortium of Breast Centers Annual Meeting, found the improved photon sensitivity of new detector technologies such as PSPMTs and CZT should be capable of reducing the radiation dose patient receive from BSGI/MBI studies by 75%.
read article 

CytRx Begins Phase 1b Clinical Trial with INNO-206 in Patients with Advanced Solid Tumors

(TheStreet) Mar 17, 2011 - CytRx Corporation today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
read article 

High-protein Diets May Raise Colon Cancer Risk

( Mar 16, 2011 - The high-protein, low-carbohydrate diets many people turn to for weight loss might have potentially harmful long-term effects on the colon, a small study hints.
read article 

Purdue Startup Hopes to Change the Way We Test Cancer Drugs

(Purdue) Mar 16, 2011 - A Purdue University scientist's nanopolymer would make it easier and cheaper for drug developers to test the effectiveness of a widely used class of cancer inhibitors.
read press release